VYOME HOLDINGS, INC. Deferred Costs, Current
VYOME HOLDINGS, INC. (HIND) had Deferred Costs, Current of $111.42 thousand as of 2025-06-30, per its 8-K filed 2025-09-02.
Financial Statements › Balance Sheet › Assets › Assets, Current › Deferred Costs, Current
us-gaap:DeferredCostsCurrent · last filed 2025-09-02
- 2025-06-30: Deferred Costs, Current $111.42K.
- 2024-12-31: Deferred Costs, Current $111.42K.
- 2016-09-30: Deferred Costs, Current $2.36M.
| Period end | Deferred Costs, Current |
|---|---|
| 2025-06-30 | $111.42K 8-K · filed 2025-09-02 |
| 2024-12-31 | $111.42K 8-K · filed 2025-09-02 |
| 2016-09-30 | $2.36M 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |